PUBLISHER: KBV Research | PRODUCT CODE: 1431194
PUBLISHER: KBV Research | PRODUCT CODE: 1431194
North America Synthetic Biology Market Size, Share & Trends Analysis Report By Application, By End-use, By Product, By Technology, By Country and Growth Forecast, 2023 - 2030
The North America Synthetic Biology Market would witness market growth of 18% CAGR during the forecast period (2023-2030).
Synthetic biology is making notable contributions to the energy sector by producing biofuels. Engineered microorganisms and plants are designed to efficiently convert biomass into renewable fuels, aligning with global efforts to transition towards sustainable and clean energy sources. Synthetic biology enables the design and engineering of microorganisms to enhance their natural abilities to produce biofuels. Microorganisms like bacteria and yeast can be modified to efficiently convert sugars from biomass into biofuel molecules such as ethanol or advanced biofuels. Metabolic engineering, a key aspect of synthetic biology, allows scientists to optimize the metabolic pathways within microorganisms. This optimization enhances the efficiency of biofuel production by directing cellular resources toward synthesizing desired fuel molecules.
Moreover, synthetic biology has revolutionized drug discovery by enabling the engineering of microorganisms to produce therapeutic proteins and antibodies. This approach expedites the development of biopharmaceuticals and facilitates the creation of personalized medicines tailored to individual patient needs. The industrial sector utilizes synthetic biology to produce bio-based materials, chemicals, and enzymes. Engineered microorganisms serve as biofactories, converting renewable resources into valuable products in a more sustainable and eco-friendly manner.
Prominent American universities and research institutions, including Stanford, Harvard, UC Berkeley, and MIT, have been actively engaged in synthetic biology research. These institutions frequently collaborate with private and public entities to advance the discipline. Government agencies such as the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Department of Energy (DOE) have contributed to synthetic biology research with financial resources and assistance. Thus, growing biofuel adoption and synthetic biology investment in North America can boost the demand in the regional synthetic biology market.
The US market dominated the North America Synthetic Biology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $13,358.6 million by 2030. The Canada market is experiencing a CAGR of 20.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 19.6% during (2023 - 2030).
Based on End-use, the market is segmented into Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Others. Based on Product, the market is segmented into Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism. Based on Technology, the market is segmented into PCR Technology, NGS Technology, Genome Editing Technology, Bioprocessing Technology and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Thermo Fisher Scientific, Inc.
- Genscript Biotech Corporation
- DNA TwoPointO Inc. (Atum)
- Integrated DNA Technologies, Inc. (Danaher Corporation)
- Eurofins Scientific SE
- OriGene Technologies, Inc.
- Twist Bioscience Corporation
- Editas Medicine, Inc.
- Agilent Technologies, Inc.
- Merck KGaA
North America Synthetic Biology Market Report Segmentation
By Application
- Healthcare
- Non-healthcare
By End-use
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Others
By Product
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
By Technology
- PCR Technology
- NGS Technology
- Genome Editing Technology
- Bioprocessing Technology
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Synthetic Biology Market, by Application
- 1.4.2 North America Synthetic Biology Market, by End-use
- 1.4.3 North America Synthetic Biology Market, by Product
- 1.4.4 North America Synthetic Biology Market, by Technology
- 1.4.5 North America Synthetic Biology Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter's Five Forces Analysis
Chapter 4. North America Synthetic Biology Market by Application
- 4.1 North America Healthcare Market by Region
- 4.2 North America Non-healthcare Market by Region
Chapter 5. North America Synthetic Biology Market by End-use
- 5.1 North America Biotechnology and Pharmaceutical Companies Market by Country
- 5.2 North America Academic and Government Research Institutes Market by Country
- 5.3 North America Others Market by Country
Chapter 6. North America Synthetic Biology Market by Product
- 6.1 North America Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country
- 6.2 North America Enzymes Market by Country
- 6.3 North America Cloning Technologies Kits Market by Country
- 6.4 North America Xeno-Nucleic Acids Market by Country
- 6.5 North America Chassis Organism Market by Country
Chapter 7. North America Synthetic Biology Market by Technology
- 7.1 North America PCR Technology Market by Country
- 7.2 North America NGS Technology Market by Country
- 7.3 North America Genome Editing Technology Market by Country
- 7.4 North America Bioprocessing Technology Market by Country
- 7.5 North America Others Market by Country
Chapter 8. North America Synthetic Biology Market by Country
- 8.1 US Synthetic Biology Market
- 8.1.1 US Synthetic Biology Market by Application
- 8.1.2 US Synthetic Biology Market by End-use
- 8.1.3 US Synthetic Biology Market by Product
- 8.1.4 US Synthetic Biology Market by Technology
- 8.2 Canada Synthetic Biology Market
- 8.2.1 Canada Synthetic Biology Market by Application
- 8.2.2 Canada Synthetic Biology Market by End-use
- 8.2.3 Canada Synthetic Biology Market by Product
- 8.2.4 Canada Synthetic Biology Market by Technology
- 8.3 Mexico Synthetic Biology Market
- 8.3.1 Mexico Synthetic Biology Market by Application
- 8.3.2 Mexico Synthetic Biology Market by End-use
- 8.3.3 Mexico Synthetic Biology Market by Product
- 8.3.4 Mexico Synthetic Biology Market by Technology
- 8.4 Rest of North America Synthetic Biology Market
- 8.4.1 Rest of North America Synthetic Biology Market by Application
- 8.4.2 Rest of North America Synthetic Biology Market by End-use
- 8.4.3 Rest of North America Synthetic Biology Market by Product
- 8.4.4 Rest of North America Synthetic Biology Market by Technology
Chapter 9. Company Profiles
- 9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Geographical Expansions:
- 9.1.6 SWOT Analysis
- 9.2 Genscript Biotech Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional & Segmental Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Geographical Expansions:
- 9.2.6 SWOT Analysis
- 9.3 DNA TwoPointO Inc. (Atum)
- 9.3.1 Company Overview
- 9.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Eurofins Scientific SE
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 SWOT Analysis
- 9.6 OriGene Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
- 9.7 Twist Bioscience Corporation
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.5.2 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Editas Medicine, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Research & Development Expenses
- 9.8.4 SWOT Analysis
- 9.9 Agilent Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Merck KGaA
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Synthetic Biology Market, 2019 - 2022, USD Million
- TABLE 2 North America Synthetic Biology Market, 2023 - 2030, USD Million
- TABLE 3 North America Synthetic Biology Market by Application, 2019 - 2022, USD Million
- TABLE 4 North America Synthetic Biology Market by Application, 2023 - 2030, USD Million
- TABLE 5 North America Healthcare Market by Region, 2019 - 2022, USD Million
- TABLE 6 North America Healthcare Market by Region, 2023 - 2030, USD Million
- TABLE 7 North America Non-healthcare Market by Region, 2019 - 2022, USD Million
- TABLE 8 North America Non-healthcare Market by Region, 2023 - 2030, USD Million
- TABLE 9 North America Synthetic Biology Market by End-use, 2019 - 2022, USD Million
- TABLE 10 North America Synthetic Biology Market by End-use, 2023 - 2030, USD Million
- TABLE 11 North America Biotechnology and Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Biotechnology and Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Academic and Government Research Institutes Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Academic and Government Research Institutes Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Synthetic Biology Market by Product, 2019 - 2022, USD Million
- TABLE 18 North America Synthetic Biology Market by Product, 2023 - 2030, USD Million
- TABLE 19 North America Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Enzymes Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Enzymes Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Cloning Technologies Kits Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Cloning Technologies Kits Market by Country, 2023 - 2030, USD Million
- TABLE 25 North America Xeno-Nucleic Acids Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Xeno-Nucleic Acids Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Chassis Organism Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Chassis Organism Market by Country, 2023 - 2030, USD Million
- TABLE 29 North America Synthetic Biology Market by Technology, 2019 - 2022, USD Million
- TABLE 30 North America Synthetic Biology Market by Technology, 2023 - 2030, USD Million
- TABLE 31 North America PCR Technology Market by Country, 2019 - 2022, USD Million
- TABLE 32 North America PCR Technology Market by Country, 2023 - 2030, USD Million
- TABLE 33 North America NGS Technology Market by Country, 2019 - 2022, USD Million
- TABLE 34 North America NGS Technology Market by Country, 2023 - 2030, USD Million
- TABLE 35 North America Genome Editing Technology Market by Country, 2019 - 2022, USD Million
- TABLE 36 North America Genome Editing Technology Market by Country, 2023 - 2030, USD Million
- TABLE 37 North America Bioprocessing Technology Market by Country, 2019 - 2022, USD Million
- TABLE 38 North America Bioprocessing Technology Market by Country, 2023 - 2030, USD Million
- TABLE 39 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 40 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 41 North America Synthetic Biology Market by Country, 2019 - 2022, USD Million
- TABLE 42 North America Synthetic Biology Market by Country, 2023 - 2030, USD Million
- TABLE 43 US Synthetic Biology Market, 2019 - 2022, USD Million
- TABLE 44 US Synthetic Biology Market, 2023 - 2030, USD Million
- TABLE 45 US Synthetic Biology Market by Application, 2019 - 2022, USD Million
- TABLE 46 US Synthetic Biology Market by Application, 2023 - 2030, USD Million
- TABLE 47 US Synthetic Biology Market by End-use, 2019 - 2022, USD Million
- TABLE 48 US Synthetic Biology Market by End-use, 2023 - 2030, USD Million
- TABLE 49 US Synthetic Biology Market by Product, 2019 - 2022, USD Million
- TABLE 50 US Synthetic Biology Market by Product, 2023 - 2030, USD Million
- TABLE 51 US Synthetic Biology Market by Technology, 2019 - 2022, USD Million
- TABLE 52 US Synthetic Biology Market by Technology, 2023 - 2030, USD Million
- TABLE 53 Canada Synthetic Biology Market, 2019 - 2022, USD Million
- TABLE 54 Canada Synthetic Biology Market, 2023 - 2030, USD Million
- TABLE 55 Canada Synthetic Biology Market by Application, 2019 - 2022, USD Million
- TABLE 56 Canada Synthetic Biology Market by Application, 2023 - 2030, USD Million
- TABLE 57 Canada Synthetic Biology Market by End-use, 2019 - 2022, USD Million
- TABLE 58 Canada Synthetic Biology Market by End-use, 2023 - 2030, USD Million
- TABLE 59 Canada Synthetic Biology Market by Product, 2019 - 2022, USD Million
- TABLE 60 Canada Synthetic Biology Market by Product, 2023 - 2030, USD Million
- TABLE 61 Canada Synthetic Biology Market by Technology, 2019 - 2022, USD Million
- TABLE 62 Canada Synthetic Biology Market by Technology, 2023 - 2030, USD Million
- TABLE 63 Mexico Synthetic Biology Market, 2019 - 2022, USD Million
- TABLE 64 Mexico Synthetic Biology Market, 2023 - 2030, USD Million
- TABLE 65 Mexico Synthetic Biology Market by Application, 2019 - 2022, USD Million
- TABLE 66 Mexico Synthetic Biology Market by Application, 2023 - 2030, USD Million
- TABLE 67 Mexico Synthetic Biology Market by End-use, 2019 - 2022, USD Million
- TABLE 68 Mexico Synthetic Biology Market by End-use, 2023 - 2030, USD Million
- TABLE 69 Mexico Synthetic Biology Market by Product, 2019 - 2022, USD Million
- TABLE 70 Mexico Synthetic Biology Market by Product, 2023 - 2030, USD Million
- TABLE 71 Mexico Synthetic Biology Market by Technology, 2019 - 2022, USD Million
- TABLE 72 Mexico Synthetic Biology Market by Technology, 2023 - 2030, USD Million
- TABLE 73 Rest of North America Synthetic Biology Market, 2019 - 2022, USD Million
- TABLE 74 Rest of North America Synthetic Biology Market, 2023 - 2030, USD Million
- TABLE 75 Rest of North America Synthetic Biology Market by Application, 2019 - 2022, USD Million
- TABLE 76 Rest of North America Synthetic Biology Market by Application, 2023 - 2030, USD Million
- TABLE 77 Rest of North America Synthetic Biology Market by End-use, 2019 - 2022, USD Million
- TABLE 78 Rest of North America Synthetic Biology Market by End-use, 2023 - 2030, USD Million
- TABLE 79 Rest of North America Synthetic Biology Market by Product, 2019 - 2022, USD Million
- TABLE 80 Rest of North America Synthetic Biology Market by Product, 2023 - 2030, USD Million
- TABLE 81 Rest of North America Synthetic Biology Market by Technology, 2019 - 2022, USD Millpion
- TABLE 82 Rest of North America Synthetic Biology Market by Technology, 2023 - 2030, USD Million
- TABLE 83 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 84 Key information - Genscript Biotech Corporation
- TABLE 85 Key Information - DNA TwoPointO Inc. (Atum)
- TABLE 86 Key Information - Integrated DNA Technologies, Inc.
- TABLE 87 Key Information - Eurofins Scientific SE
- TABLE 88 Key Information - OriGene Technologies, Inc.
- TABLE 89 Key Information - Twist Bioscience Corporation
- TABLE 90 Key Information - Editas Medicine, Inc.
- TABLE 91 key Information - Agilent Technologies, Inc.
- TABLE 92 key Information - Merck KGaA
